Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mimedx (MDXG) Assets (2016 - 2025)

Historic Assets for Mimedx (MDXG) over the last 16 years, with Q3 2025 value amounting to $319.0 million.

  • Mimedx's Assets rose 3079.12% to $319.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $319.0 million, marking a year-over-year increase of 3079.12%. This contributed to the annual value of $263.9 million for FY2024, which is 1040.3% up from last year.
  • Latest data reveals that Mimedx reported Assets of $319.0 million as of Q3 2025, which was up 3079.12% from $291.1 million recorded in Q2 2025.
  • Over the past 5 years, Mimedx's Assets peaked at $319.0 million during Q3 2025, and registered a low of $168.2 million during Q1 2023.
  • In the last 5 years, Mimedx's Assets had a median value of $189.0 million in 2023 and averaged $213.0 million.
  • In the last 5 years, Mimedx's Assets tumbled by 1537.61% in 2021 and then surged by 3944.29% in 2023.
  • Quarter analysis of 5 years shows Mimedx's Assets stood at $187.9 million in 2021, then dropped by 8.78% to $171.4 million in 2022, then surged by 39.44% to $239.0 million in 2023, then increased by 10.4% to $263.9 million in 2024, then grew by 20.87% to $319.0 million in 2025.
  • Its Assets was $319.0 million in Q3 2025, compared to $291.1 million in Q2 2025 and $270.4 million in Q1 2025.